Search Results 721-730 of 13535 for meditation
Regorafenib is a type of drug called a kinase inhibitor. Regorafenib interferes with how some kinase proteins work. Some of these kinases in cancer cells might ...
About this study. The purpose of this study is to determine, through in-depth interviews, the motivations, values, preferences, and expectations of VCA ...
The purpose of this study is to determine if INCB039110 in combination with corticosteroids is safe and tolerable for treating patients with Grade IIB-IVD acute ...
The purpose of this study is to evaluate the impact of interventions on important CV biomarkers to provide valuable information on the mechanism linking ...
Esterov D, Schultz BA, Bottemiller KL, Boontaveekul SD. Serotonin Syndrome Precipitated by Amantadine in a Patient With Persistent Post Concussive Symptoms ...
The purpose of this study is to assess the safety, tolerability, pharmaokinetics, and preliminary effectiveness of mosunetuzumab in participants with relapsed ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to: To identify predictors of inferior overall survival in HES/IHE patients including molecular parameters ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.